Transaction · 0001493152-24-000154

Jayasuriya Anula

Jayasuriya Anula, DIR, reported an open-market or private purchase at Lineage Cell Therapeutics, Inc. involving 10000.000000 shares for an estimated $10900.00. Reported holdings after the transaction were 10000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
LCTXLineage Cell Therapeutics, Inc.
Filing timeJan 02
Trade dateDec 29, 2023
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNew position: there is no prior reported position to use as a percentage baseline.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

LCTX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
LCTX since 2024-01-02Filed 999 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001493152-24-000154
Common Shares, no par value
Transaction date
Dec 29, 2023
Filed Jan 02, 2024, 07:08 PM · 4d delay
Shares
10.0k sh
$1.09 per share
Estimated value
$10.9k
Computed from shares × price
Holdings after
10.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Director Buy Direct Ownership Large Holdings Increase
+32score
Filing-only score

+32

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.08 to not more than $1.09. The reporting person undertakes to provi…

  2. F2

    Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.

Original filing · 0001493152-24-000154
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

LCTX